Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Entasis Therapeutics logo

Entasis Therapeutics

Recent Finacing

Non-Equity

Recent Raise

$3.8M

Entasis Therapeutics develops antibiotics for drug-resistant Gram-negative infections using a discovery platform combining bacterial genomics, molecular dynamics, and structure-based design, advancing multiple candidates from preclinical to clinical stages.

Founded 2015
Massachusetts, United States
51-100
Publicly Traded
entasistx.com

Highlights

Focus Areas

Biotechnology
Health Care
Medical
Pharmaceutical

Recent Investors

Eventide Asset Management logo
Frazier Healthcare Partners logo
Novo Holdings logo
Clarus logo
AstraZeneca logo
Sofinnova Ventures logo
Pivotal bioVenture Partners logo
TPG Biotech logo
CARB-X logo

Financials

$85.7M

Total Raised

3

Funding rounds

9

Investors